AU Stock MarketDetailed Quotes
RAD Radiopharm Theranostics Ltd
- 0.036
- -0.003-7.69%
20min DelayMarket Closed May 17 15:50 AET
16.57MMarket Cap-336P/E (Static)
0.038High0.035Low762.96KVolume0.038Open0.039Pre Close27.72KTurnover0.16052wk High0.27%Turnover Ratio460.37MShares0.03552wk Low-0.136EPS TTM10.14MFloat Cap0.495Historical HighLossP/E (Static)281.61MShs Float0.035Historical Low-0.107EPS LYR7.69%Amplitude--Dividend TTM0.68P/B1Lot Size--Div YieldTTM
About Radiopharm Theranostics Ltd Company
Radiopharm Theranostics Ltd is a Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialisation of health technologies.
Company Profile
SymbolRAD
Company NameRadiopharm Theranostics Ltd
Founded2021
MarketASX
Fiscal Year Ends06-30
Address62 Lygon Street Level 3, Carlton South
CityMelbourne
CountryAustralia
Zip Code3053
Phone+61 398245254
Company Executives
- Name
- Position
- Salary
- Riccardo Canevari
- Chief Executive Officer, Managing Director and Executive Director
- --
- David Mozley
- Chief Medical Officer
- --
- Thom Tulip
- Chief Business Officer
- --
- Vittorio Puppo
- Chief Operating Officer
- --
- Paul Alex Hopper
- Executive Chairman of the Board
- --
- Michael Baker
- Non-Executive Director
- --
- Ian Turner
- Non-Executive Director
- --
- Hester Larkin
- Non-Executive Director
- --
- Leila Alland
- Non-Executive Director
- --
- Phillip Hains
- Joint Company Secretary
- --
- Nathan Jong
- Joint Company Secretary
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg